| 发明名称 |
Compound, pharmaceutical preparation and their use for ribavirin-interferon alpha compound therapy |
| 摘要 |
<p>A method for treating a patient having chronic hepatitis C infection to eradicate detectable HCV-RNA involving a combination therapy using a therapeutically effective amount of ribavirin derivative of formula (I) and a therapeutically effective amount of interferon-alpha for a time period of from 20 up to 80 weeks.</p> |
| 申请公布号 |
CZ20011130(A3) |
申请公布日期 |
2001.08.15 |
| 申请号 |
CZ20010001130 |
申请日期 |
1999.10.14 |
| 申请人 |
SCHERING CORPORATION |
发明人 |
GANGULY ASHIT K.;MCCORMICK JINPING;LOVEY RAYMOND G.;BENNET FRANK;SAKSENA ANIL K.;GIRIJAVALLABHAN VIYYOOR M. |
| 分类号 |
A61K31/7042;A61K31/7052;A61K31/7056;A61K38/21;A61P31/12;A61P31/14;A61P31/20;A61P43/00;C07H19/056;(IPC1-7):C07H19/056;A61K31/705 |
主分类号 |
A61K31/7042 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
